Perinatology.com

Maternal Heart and Cardiovascular Conditions in Pregnancy

Overview

Maternal cardiovascular disease ranges from relatively well tolerated repaired congenital lesions and mild regurgitant disease to very high-risk conditions such as pulmonary hypertension, mechanical valves, severe stenotic lesions, major aortopathy, complex congenital physiology, and cardiomyopathy with ventricular dysfunction.

This page follows the same practical reference flow as other Perinatology maternal-condition pages and is meant to complement the interactive Cardiac Disease in Pregnancy Tool. The emphasis is on daily-use clinical organization: symptom escalation, lesion-specific pregnancy risk, delivery planning, postpartum observation, and longer-term cardiovascular follow-up.

For interactive lesion-based risk stratification, mWHO/NYHA framing, SMFM symptom triage, and EMR-ready planning language, use the companion calculator: Cardiac Disease in Pregnancy Tool.

General Approach

Maternal cardiac disease in pregnancy is often best approached first by physiology rather than by diagnosis name alone. Ventricular function, pulmonary pressures, cyanosis, outflow obstruction, aortic dimensions, arrhythmia burden, and anticoagulation needs may matter more clinically than a lesion label by itself.

Clinical points

  • Separate normal pregnancy symptoms from symptoms that are clearly out of proportion to physiologic pregnancy change.
  • Risk should be informed by symptoms, functional class, ventricular performance, oxygen saturation, rhythm history, pulmonary vascular disease, and aortic features.
  • Patients with severe structural disease, pulmonary hypertension, mechanical valves, prior cardiomyopathy, or aortopathy usually benefit from multidisciplinary planning.
  • Delivery planning should specify location, hemodynamic goals, anesthesia considerations, anticoagulation timing, and postpartum observation rather than simply stating “tertiary-center delivery.”
Practical question: is the patient likely to fail because of fixed output, pulmonary vascular disease, ventricular dysfunction, arrhythmia, thromboembolic risk, or postpartum fluid shifts?

Congenital Heart Disease, Valvular Disease, and Aortopathy

Pregnancy risk in congenital and valvular disease depends less on the lesion name than on the presence of obstruction, ventricular dysfunction, cyanosis, pulmonary hypertension, arrhythmia, prosthetic material, prior intervention, and residual hemodynamic burden. Aortopathy deserves separate attention because pregnancy and postpartum increase aortic wall stress.

Clinical points

  • Regurgitant lesions with preserved ventricular function are often better tolerated than stenotic lesions.
  • Moderate or severe mitral stenosis and severe aortic stenosis may decompensate with tachycardia, volume shifts, or hemorrhage.
  • Repaired congenital lesions still require review of residual shunt, ventricular function, pulmonary pressures, saturation, and arrhythmia burden.
  • Fontan physiology, systemic right ventricle, cyanotic disease, and complex repaired congenital disease usually require higher-level pregnancy planning.
  • Aortopathy evaluation should document syndrome if known, root and ascending aortic dimensions, interval growth, and whether delivery/postpartum imaging plans are in place.
  • Chest pain, back pain, pulse deficit, severe hypertension, or neurologic symptoms in a patient with aortopathy should trigger urgent consideration of dissection.

Arrhythmias and Long QT Syndrome

Palpitations are common in pregnancy, but a patient with syncope, sustained tachyarrhythmia, wide-complex rhythm, inherited arrhythmia syndrome, or structural heart disease should not be managed as though symptoms are automatically benign. Long QT syndrome deserves explicit medication, electrolyte, intrapartum, and postpartum planning.

Clinical points

  • Evaluate symptom quality, duration, onset/offset, associated syncope, and family history of sudden death.
  • ECG is foundational; ambulatory monitoring may help when symptoms are intermittent but concerning.
  • Review reversible contributors such as anemia, thyroid disease, infection, electrolyte loss, stimulant exposure, or medication effects.
  • Patients with Long QT syndrome should have explicit review of QT-prolonging medications and correction of hypokalemia or hypomagnesemia.
  • Postpartum may be the highest-risk period for Long QT–related events, especially when sleep deprivation and adrenergic stress are prominent.

Cardiomyopathy, Peripartum Cardiomyopathy, and Heart Failure

Heart failure in pregnancy or postpartum may reflect preexisting cardiomyopathy, peripartum cardiomyopathy, valvular disease, congenital heart disease, ischemia, myocarditis, or severe hypertensive disease. The daily-use challenge is deciding when dyspnea and edema are no longer physiologic.

Clinical points

  • Orthopnea, pulmonary edema, resting dyspnea, progressive tachycardia, or reduced exercise tolerance should prompt urgent evaluation.
  • Peripartum cardiomyopathy should be considered in late pregnancy or postpartum patients with new systolic dysfunction and compatible symptoms.
  • Volume management and avoidance of unnecessary fluid loading are especially important around delivery and immediately postpartum.
  • Postpartum decompensation may occur even when antenatal symptoms seemed modest.
  • Future-pregnancy counseling should be explicit when prior peripartum cardiomyopathy or persistent ventricular dysfunction is present.

Pulmonary Hypertension, Cyanotic Disease, and High-Risk Physiology

Pulmonary arterial hypertension, Eisenmenger physiology, and some cyanotic or advanced congenital circulations remain among the highest-risk cardiovascular conditions in pregnancy. These patients often require expert multidisciplinary management and extended postpartum vigilance.

Clinical points

  • Pregnancy is generally contraindicated in pulmonary arterial hypertension because maternal risk remains extremely high.
  • Avoid hypoxemia, acidosis, severe pain, hemorrhage, hypotension, and fluid overload.
  • Even apparently stable patients may deteriorate rapidly intrapartum or postpartum.
  • Cyanosis, low oxygen saturation, RV dysfunction, and thrombosis history materially worsen outlook.
  • Fontan and complex congenital patients require review of ventricular function, AV valve regurgitation, arrhythmias, thrombosis history, saturation, and hepatic disease.

Mechanical Heart Valves, Anticoagulation, and Thromboembolic Issues

Anticoagulation decisions in pregnancy complicated by cardiac disease are among the most difficult management problems in daily practice. Mechanical valves, atrial arrhythmias, ventricular dysfunction, and prior thrombosis each require structured planning before delivery.

Clinical points

  • Mechanical valves require a written antepartum, peridelivery, neuraxial, and postpartum anticoagulation plan.
  • Do not leave delivery timing or labor-management questions unresolved in a therapeutically anticoagulated patient.
  • Hemorrhage risk and thrombosis risk both rise around delivery, so coordination matters more than last-minute improvisation.
  • Clarify valve type, thrombosis history, prior regimen success, and monitoring strategy early.
  • Postpartum restart timing should be explicit in the chart before delivery occurs.

Delivery Planning and Postpartum Follow-up

Delivery planning for maternal cardiovascular disease should say more than “deliver at tertiary center.” It should specify preferred mode of delivery, analgesia goals, fluid strategy, anticoagulation timing, telemetry needs, immediate postpartum observation, and warning symptoms after discharge.

Clinical points

  • Vaginal delivery is preferred for many stable patients, but that should not be assumed in every lesion or physiology.
  • Early neuraxial analgesia is often helpful to limit hemodynamic stress.
  • Avoid abrupt preload or afterload shifts in patients with fixed obstruction, severe ventricular dysfunction, pulmonary hypertension, or major aortic disease.
  • Identify who needs telemetry, ICU backup, or extended postpartum observation.
  • Postpartum fluid shifts may worsen heart failure, arrhythmias, hypertensive complications, and aortic events.

Long-term Cardiovascular Risk

Pregnancy complications and maternal cardiovascular disease should not remain isolated within obstetric records. The postpartum and interpregnancy period is increasingly recognized as an opportunity to reduce later-life cardiovascular risk and to improve future pregnancy readiness.

Clinical points

  • Adverse pregnancy outcomes and pregnancy-associated cardiovascular disease should be communicated clearly to primary care and cardiology clinicians.
  • Patients benefit from counseling regarding blood pressure, weight, exercise, diabetes risk, lipid management, and follow-up continuity.
  • Prior peripartum cardiomyopathy, hypertensive disease, structural heart disease, or aortopathy has implications for future pregnancy planning.
  • Postpartum recovery does not eliminate later cardiovascular risk.
References
  1. De Backer J, Budts W, Roos-Hesselink J, et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025;46(43):4462-4568. PMID: 40878294
  2. American College of Obstetricians and Gynecologists. Practice Bulletin No. 212: Pregnancy and Heart Disease. Obstet Gynecol. 2019;133(5):e320-e356. PMID: 31022123
  3. Hameed AB, Licon E, et al. SMFM Consult Series #73: Heart failure in pregnancy and postpartum. 2025. DOI link
  4. Combs CA, Atallah F, et al. SMFM Special Statement: Cardiovascular symptom triage. 2025. DOI link
  5. Silversides CK, Grewal J, et al. CARPREG II Study. J Am Coll Cardiol. 2018. PMID: 29793631
  6. van Hagen IM, Roos-Hesselink JW, et al. ROPAC registry: mechanical valves in pregnancy. Circulation. 2015. PMID: 26100109
  7. Elkayam U, Goland S, et al. High-risk cardiac disease in pregnancy (Parts I & II). JACC. 2016. PMID: 27443437 / 27443948
  8. Seth R, Moss AJ, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007. PMID: 17349890
  9. Sliwa K, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy review. Eur J Heart Fail. 2010. PMID: 20675664
  10. Warnes CA. Pulmonary hypertension in pregnancy. Int J Cardiol. 2004. PMID: 15590074
  11. Meijboom LJ, et al. Marfan syndrome and aortic root growth in pregnancy. Eur Heart J. 2005. PMID: 15681576
  12. Immer FF, et al. Aortic dissection in pregnancy. Ann Thorac Surg. 2003. PMID: 12842575
  13. Lewey J, Honigberg MC, et al. AHA Scientific Statement: Postpartum cardiovascular risk. Circulation. 2024. PMID: 38346104